Page last updated: 2024-10-24

negative regulation of signaling

Definition

Target type: biologicalprocess

Any process that stops, prevents, or reduces the frequency, rate or extent of a signaling process. [GOC:mtg_signal]

Negative regulation of signaling is a fundamental biological process that ensures appropriate cellular responses to stimuli. It involves mechanisms that dampen, suppress, or reduce the intensity or duration of signal transduction pathways. This regulation is essential for maintaining cellular homeostasis, preventing overstimulation, and orchestrating precise responses to specific stimuli.

The process typically involves interactions between signaling molecules, proteins, and other cellular components. Key mechanisms of negative regulation include:

1. **Inhibition of Receptor Activation:** Signaling cascades often initiate with the activation of receptors on the cell surface. Negative regulation can occur at this step by preventing receptor activation or by promoting receptor inactivation. This can be achieved through mechanisms such as:
* **Ligand sequestration:** Molecules that bind to ligands and prevent them from interacting with their receptors.
* **Receptor antagonists:** Molecules that bind to receptors without activating them, blocking the binding of agonists.
* **Desensitization:** Receptor modifications, such as phosphorylation or ubiquitination, that reduce their sensitivity to signaling.

2. **Downstream Signaling Pathway Inhibition:** Once a receptor is activated, it initiates a cascade of signaling events that involve various protein interactions. Negative regulation can occur at different points along this pathway, targeting specific proteins or enzymatic activities:
* **Protein phosphorylation/dephosphorylation:** Kinases and phosphatases regulate the activity of signaling proteins by adding or removing phosphate groups, respectively.
* **Protein degradation:** Targeting signaling proteins for degradation by proteasomes or other degradation pathways.
* **Inhibition of second messenger production:** Blocking the synthesis or activity of intracellular signaling molecules, such as cAMP, IP3, or calcium ions.

3. **Feedback Loops:** Negative feedback loops are common mechanisms where the output of a signaling pathway inhibits its own activation. This helps to fine-tune signaling responses and prevent excessive activation:
* **Negative feedback loops can involve:**
* The final downstream effector inhibiting an upstream step in the pathway.
* A signaling molecule activating a phosphatase that deactivates the initiating kinase.

4. **Competing Signaling Pathways:** Cells often have multiple signaling pathways that can interact and influence each other. Activation of one pathway can negatively regulate another pathway, thereby ensuring specific and balanced responses to various stimuli.

Overall, negative regulation of signaling is crucial for maintaining cellular homeostasis, preventing uncontrolled activation of pathways, and ensuring precise responses to various stimuli. It involves a diverse array of mechanisms that fine-tune signaling pathways and contribute to the complexity and adaptability of cellular signaling networks.'
"

Proteins (2)

ProteinDefinitionTaxonomy
Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoformA protein phosphatase 3 catalytic subunit alpha that is encoded in the genome of human. [PRO:CNA, UniProtKB:Q08209]Homo sapiens (human)
Serine/threonine-protein phosphatase 2B catalytic subunit beta isoformA serine/threonine-protein phosphatase 2B catalytic subunit beta isoform that is encoded in the genome of human. [PRO:DNx, UniProtKB:P16298]Homo sapiens (human)

Compounds (4)

CompoundDefinitionClassesRoles
tacrolimustacrolimus (anhydrous) : A macrolide lactam containing a 23-membered lactone ring, originally isolated from the fermentation broth of a Japanese soil sample that contained the bacteria Streptomyces tsukubaensis.

Tacrolimus: A macrolide isolated from the culture broth of a strain of Streptomyces tsukubaensis that has strong immunosuppressive activity in vivo and prevents the activation of T-lymphocytes in response to antigenic or mitogenic stimulation in vitro.
macrolide lactambacterial metabolite;
immunosuppressive agent
tamoxifenstilbenoid;
tertiary amino compound
angiogenesis inhibitor;
antineoplastic agent;
bone density conservation agent;
EC 1.2.3.1 (aldehyde oxidase) inhibitor;
EC 2.7.11.13 (protein kinase C) inhibitor;
estrogen antagonist;
estrogen receptor antagonist;
estrogen receptor modulator
cyclosporineramihyphin A: one of the metabolites produced by Fusarium sp. S-435; RN given refers to cpd with unknown MFhomodetic cyclic peptideanti-asthmatic drug;
anticoronaviral agent;
antifungal agent;
antirheumatic drug;
carcinogenic agent;
dermatologic drug;
EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor;
geroprotector;
immunosuppressive agent;
metabolite
bi 201335faldaprevir: inhibits hepatitis C virus NS3 protease